Sleep architecture
Early animal research reported changes in delta and spindle EEG activity under specific experimental conditions.
P—23 • Preclinical research profile
A concise educational overview of a nonapeptide identified in early sleep research and studied across sleep architecture, circadian biology, and neuroendocrine signaling.
Name
Delta sleep-inducing peptide; sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Compound overview
DSIP was identified in research involving cerebral venous blood from rabbits exposed to sleep-inducing stimulation. Early studies examined whether the purified nonapeptide influenced delta-wave and spindle activity.
Subsequent work explored sleep, circadian, neurotransmitter, hormonal, and stress-response effects, but findings have varied by species, route, timing, and experimental design.
Mechanism under study
DSIP has no single confirmed receptor or clinically established mechanism. Research suggests broad neuromodulatory effects rather than a simple direct sleep switch.
Early animal research reported changes in delta and spindle EEG activity under specific experimental conditions.
Studies have examined relationships with locomotor patterns, sleep timing, and circadian organization.
Older research reported changes in selected neurotransmitter and hormonal measures, with uncertain human significance.
The age and heterogeneity of the evidence make replication and modern controlled studies especially important.
Current research areas
Evidence summary
The evidence is limited, mixed, and largely based on older animal or exploratory studies. Clinical effectiveness and long-term safety are unproven.
This profile is provided for scientific education only. It is not sleep advice, medical guidance, dosing information, or instructions for DSIP use. DSIP is not FDA approved.
A curated primary-source reference list will be added during the next educational expansion.